TNX-650
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TNX-650, covering 2008-05-09 to 2008-05-09. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy Study of TNX-650 to Treat Refractory Hodgkin's Lymphoma [Phase 1, Phase 2]